Armas Pharmaceuticals Inc.
15 drugs in NADAC|15 Generic,0 Brand
Armas Pharmaceuticals Inc. lists 15 NDCs in the CMS NADAC file (15 generic, 0 brand), at an average NADAC of $1.57 per unit, with a week-over-week move of -0.3% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
15
15G / 0B
Avg Price / Unit
$1.5677
$0.38 – $4.69
Avg 7d Change
-0.31%
Across 7 drugs with changes
7d Activity
of 15 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
imatinib mesylate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Penicillin-class Antibacterial therapeutic class
Review the broader class where Armas Pharmaceuticals Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Armas Pharmaceuticals Inc. make?
Armas Pharmaceuticals Inc. lists 15 NDCs in the CMS NADAC file — 15 generic and 0 brand products.
What is the average price of Armas Pharmaceuticals Inc. drugs?
The average NADAC across Armas Pharmaceuticals Inc.'s portfolio is $1.5677 per unit, ranging from $0.3787 to $4.6876.
What types of drugs does Armas Pharmaceuticals Inc. make?
Armas Pharmaceuticals Inc. makes drugs across 10 FDA pharmacologic classes. The most common by NDC count are Penicillin-class Antibacterial (2), Kinase Inhibitor (2), Histamine-1 Receptor Antagonist (2), Nucleoside Metabolic Inhibitor (2), Antifibrinolytic Agent (2).
Has Armas Pharmaceuticals Inc. had any drug recalls?
No FDA enforcement recalls are matched to Armas Pharmaceuticals Inc. in the openFDA feed.
How has Armas Pharmaceuticals Inc.'s pricing changed recently?
Over the past 7 days, 4 Armas Pharmaceuticals Inc. products rose and 3 fell, with a portfolio-wide average change of -0.3%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
MEROPENEM IV 1 GM VIAL Meropenem | $4.6875 per EA | +0.40% |
PIPERACIL-TAZOBACT 3.375 GM VL piperacillin and tazobactam | $3.4926 per EA | — |
AMPICILLIN 2 GM VIAL Ampicillin Sodium | $3.2338 per EA | — |
THIAMINE 200 MG/2 ML VIAL Thiamine Hydrochloride | $2.2468 per ML | +3.90% |
IMATINIB MESYLATE 400 MG TAB imatinib mesylate | $2.0356 per EA | — |
KETOTIFEN 0.025% (0.035%) DROP Ketotifen Fumarate | $1.2940 per ML | -0.78% |
TIMOLOL MALEATE 0.5% EYE DROP Timolol maleate | $1.2411 per EA | — |
DEXAMETHASONE 10 MG/ML VIAL Dexamethasone Sodium Phosphate | $1.1568 per ML | -10.52% |
DIPHENHYDRAMINE 50 MG/ML VIAL Diphenhydramine Hydrochloride | $1.0542 per ML | +4.33% |
DIPHENHYDRAMINE 50 MG/ML VIAL Diphenhydramine Hydrochloride | $0.8980 per ML | -3.81% |
IMATINIB MESYLATE 100 MG TAB imatinib mesylate | $0.4912 per EA | — |
CAPECITABINE 500 MG TABLET Capecitabine | $0.4615 per EA | — |
CAPECITABINE 150 MG TABLET Capecitabine | $0.4399 per EA | — |
TRANEXAMIC ACID 1,000 MG/10 ML Tranexamic Acid | $0.4035 per ML | +4.32% |
TRANEXAMIC ACID 1,000 MG/10 ML TRANEXAMIC ACID | $0.3787 per ML | — |